189 related articles for article (PubMed ID: 22905486)
1. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
[TBL] [Abstract][Full Text] [Related]
2. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer.
Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y
Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223
[TBL] [Abstract][Full Text] [Related]
3. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
4. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinoma.
Wang Y; Song D; Costanza F; Ji G; Fan Z; Cai J; Li Q
J Biomed Nanotechnol; 2014 Nov; 10(11):3244-52. PubMed ID: 26000384
[TBL] [Abstract][Full Text] [Related]
6. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
7. Preparation of a Thermosensitive Gel Composed of a mPEG-PLGA-PLL-cRGD Nanodrug Delivery System for Pancreatic Tumor Therapy.
Shen M; Xu YY; Sun Y; Han BS; Duan YR
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20530-7. PubMed ID: 26366977
[TBL] [Abstract][Full Text] [Related]
8. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
[TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas.
Liu P; Sun Y; Wang Q; Sun Y; Li H; Duan Y
Biomaterials; 2014 Jan; 35(2):760-70. PubMed ID: 24148242
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
[TBL] [Abstract][Full Text] [Related]
11. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery.
Liu Y; Liu C; Li M; Liu F; Feng L; Zhang L; Zhang N
J Biomed Nanotechnol; 2014 Jun; 10(6):948-58. PubMed ID: 24749390
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
13. Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system.
Guo L; Zhang H; Wang F; Liu P; Wang Y; Xia G; Liu R; Li X; Yin H; Jiang H; Chen B
Int J Nanomedicine; 2015; 10():4535-47. PubMed ID: 26213467
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles In Vitro and In Vivo.
Guo L; Chen B; Liu R; Xia G; Wang Y; Li X; Wei C; Wang X; Jiang H
J Nanosci Nanotechnol; 2015 May; 15(5):3710-9. PubMed ID: 26504996
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
16. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
17. Idarubicin-loaded methoxy poly(ethylene glycol)-
Liang B; Li N; Zhang S; Qi A; Feng J; Jing W; Shi C; Ma Z; Gao S
Int J Nanomedicine; 2019; 14():543-556. PubMed ID: 30666113
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice.
Wang Y; Liu P; Qiu L; Sun Y; Zhu M; Gu L; Di W; Duan Y
Biomaterials; 2013 May; 34(16):4068-4077. PubMed ID: 23480957
[TBL] [Abstract][Full Text] [Related]
19. Degradability, bioactivity, and osteogenesis of biocomposite scaffolds of lithium-containing mesoporous bioglass and mPEG-PLGA-b-PLL copolymer.
Cai Y; Guo L; Shen H; An X; Jiang H; Ji F; Niu Y
Int J Nanomedicine; 2015; 10():4125-36. PubMed ID: 26150718
[TBL] [Abstract][Full Text] [Related]
20. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
